Michael S Aberman Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael S Aberman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael S Aberman. Michael S Aberman is SVP Strategy Investor Relation in REGENERON PHARMACEUTICALS INC ($REGN) and VP Strategy and Investor Relat in REGENERON PHARMACEUTICALS INC ($REGN) and VP, Strat and Invest Relations in REGENERON PHARMACEUTICALS INC ($REGN).
Michael S Aberman in REGENERON PHARMACEUTICALS, INC.
Trading Symbol: REGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael S Aberman: SVP Strategy Investor Relation, VP Strategy and Investor Relat, VP, Strat and Invest Relations
Holdings: 9,193 shares
Current Value: $3,288,244
Latest Transaction: Jun 23 2017
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael S Aberman in REGENERON PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 30.63 | 4,500 | 137,835 | 3,000 | |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 541.00 | 100 | 54,100 | 4,693 | 4.8 K to 4.7 K (-2.09 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 538.30 | 100 | 53,830 | 4,793 | 4.9 K to 4.8 K (-2.04 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 537.50 | 100 | 53,750 | 4,893 | 5 K to 4.9 K (-2.00 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 536.52 | 400 | 214,608 | 4,993 | 5.4 K to 5 K (-7.42 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 534.51 | 200 | 106,902 | 5,393 | 5.6 K to 5.4 K (-3.58 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 533.48 | 200 | 106,696 | 5,593 | 5.8 K to 5.6 K (-3.45 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 532.27 | 200 | 106,454 | 5,793 | 6 K to 5.8 K (-3.34 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 531.51 | 274 | 145,634 | 5,993 | 6.3 K to 6 K (-4.37 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 530.66 | 100 | 53,066 | 6,267 | 6.4 K to 6.3 K (-1.57 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 529.61 | 100 | 52,961 | 6,367 | 6.5 K to 6.4 K (-1.55 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 526.02 | 100 | 52,602 | 6,467 | 6.6 K to 6.5 K (-1.52 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 525.21 | 395 | 207,458 | 6,567 | 7 K to 6.6 K (-5.67 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 510.02 | 1,961 | 1,000,149 | 6,962 | 8.9 K to 7 K (-21.98 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 510.02 | 270 | 137,705 | 8,923 | 9.2 K to 8.9 K (-2.94 %) |
Jun 23 2017 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 30.63 | 4,500 | 137,835 | 9,193 | 4.7 K to 9.2 K (+95.89 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | A | 381.92 | 21,675 | 8,278,116 | 21,675 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | A | 555.67 | 25,500 | 14,169,585 | 25,500 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 4,000 | 96,000 | 166 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 4,000 | 96,000 | 16,498 | 12.5 K to 16.5 K (+32.01 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 482.56 | 100 | 48,256 | 12,498 | 12.6 K to 12.5 K (-0.79 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 481.59 | 1,100 | 529,749 | 12,598 | 13.7 K to 12.6 K (-8.03 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 480.70 | 800 | 384,560 | 13,698 | 14.5 K to 13.7 K (-5.52 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 479.39 | 500 | 239,695 | 14,498 | 15 K to 14.5 K (-3.33 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 478.46 | 530 | 253,584 | 14,998 | 15.5 K to 15 K (-3.41 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 477.59 | 573 | 273,659 | 15,528 | 16.1 K to 15.5 K (-3.56 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 476.53 | 740 | 352,632 | 16,101 | 16.8 K to 16.1 K (-4.39 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 475.83 | 200 | 95,166 | 16,841 | 17 K to 16.8 K (-1.17 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 474.79 | 300 | 142,437 | 17,041 | 17.3 K to 17 K (-1.73 %) |
Mar 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 476.50 | 5,157 | 2,457,311 | 17,341 | 22.5 K to 17.3 K (-22.92 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 7,500 | 180,000 | 14,168 | |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 3,898 | 93,552 | 4,166 | |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 472.14 | 100 | 47,214 | 22,498 | 22.6 K to 22.5 K (-0.44 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 471.24 | 100 | 47,124 | 22,598 | 22.7 K to 22.6 K (-0.44 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 470.97 | 142 | 66,878 | 22,698 | 22.8 K to 22.7 K (-0.62 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 469.68 | 100 | 46,968 | 22,840 | 22.9 K to 22.8 K (-0.44 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 468.92 | 100 | 46,892 | 22,940 | 23 K to 22.9 K (-0.43 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 465.42 | 500 | 232,710 | 23,040 | 23.5 K to 23 K (-2.12 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 464.44 | 500 | 232,220 | 23,540 | 24 K to 23.5 K (-2.08 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 463.60 | 1,500 | 695,400 | 24,040 | 25.5 K to 24 K (-5.87 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 462.84 | 400 | 185,136 | 25,540 | 25.9 K to 25.5 K (-1.54 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 457.91 | 3,665 | 1,678,240 | 25,940 | 29.6 K to 25.9 K (-12.38 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 457.91 | 393 | 179,959 | 29,605 | 30 K to 29.6 K (-1.31 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 7,500 | 180,000 | 29,998 | 22.5 K to 30 K (+33.34 %) |
Mar 19 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 3,898 | 93,552 | 22,498 | 18.6 K to 22.5 K (+20.96 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 30.63 | 7,500 | 229,725 | 7,500 | |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 420.64 | 400 | 168,256 | 18,600 | 19 K to 18.6 K (-2.11 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 419.52 | 1,103 | 462,731 | 19,000 | 20.1 K to 19 K (-5.49 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 418.33 | 800 | 334,664 | 20,103 | 20.9 K to 20.1 K (-3.83 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 417.23 | 471 | 196,515 | 20,903 | 21.4 K to 20.9 K (-2.20 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 416.31 | 600 | 249,786 | 21,374 | 22 K to 21.4 K (-2.73 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 427.94 | 3,590 | 1,536,305 | 21,974 | 25.6 K to 22 K (-14.04 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 427.94 | 536 | 229,376 | 25,564 | 26.1 K to 25.6 K (-2.05 %) |
Feb 25 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 30.63 | 7,500 | 229,725 | 26,100 | 18.6 K to 26.1 K (+40.32 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 7,500 | 180,000 | 21,668 | |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 406.24 | 100 | 40,624 | 18,600 | 18.7 K to 18.6 K (-0.53 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 405.56 | 900 | 365,004 | 18,700 | 19.6 K to 18.7 K (-4.59 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 404.55 | 1,692 | 684,499 | 19,600 | 21.3 K to 19.6 K (-7.95 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 403.72 | 600 | 242,232 | 21,292 | 21.9 K to 21.3 K (-2.74 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 402.51 | 300 | 120,753 | 21,892 | 22.2 K to 21.9 K (-1.35 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Sell | S | 401.54 | 100 | 40,154 | 22,192 | 22.3 K to 22.2 K (-0.45 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 402.05 | 3,361 | 1,351,290 | 22,292 | 25.7 K to 22.3 K (-13.10 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Payment of Exercise | F | 402.05 | 447 | 179,716 | 25,653 | 26.1 K to 25.7 K (-1.71 %) |
Feb 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 7,500 | 180,000 | 26,100 | 18.6 K to 26.1 K (+40.32 %) |
Dec 18 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | A | 399.66 | 30,000 | 11,989,800 | 30,000 | |
Aug 26 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 3,000 | 72,000 | 8,064 | |
Aug 26 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 3,000 | 72,000 | 18,600 | 15.6 K to 18.6 K (+19.23 %) |
Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 52.03 | 8,750 | 455,263 | 26,250 | |
Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 350.00 | 3,611 | 1,263,850 | 15,600 | 19.2 K to 15.6 K (-18.80 %) |
Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 351.06 | 3,843 | 1,349,124 | 19,211 | 23.1 K to 19.2 K (-16.67 %) |
Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 351.06 | 1,296 | 454,974 | 23,054 | 24.4 K to 23.1 K (-5.32 %) |
Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 52.03 | 8,750 | 455,263 | 24,350 | 15.6 K to 24.4 K (+56.09 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 30.63 | 7,500 | 229,725 | 15,000 | |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 334.24 | 300 | 100,272 | 15,600 | 15.9 K to 15.6 K (-1.89 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 333.50 | 948 | 316,158 | 15,900 | 16.8 K to 15.9 K (-5.63 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 332.41 | 1,100 | 365,651 | 16,848 | 17.9 K to 16.8 K (-6.13 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 331.16 | 200 | 66,232 | 17,948 | 18.1 K to 17.9 K (-1.10 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 330.87 | 200 | 66,174 | 18,148 | 18.3 K to 18.1 K (-1.09 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 329.34 | 200 | 65,868 | 18,348 | 18.5 K to 18.3 K (-1.08 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 328.60 | 100 | 32,860 | 18,548 | 18.6 K to 18.5 K (-0.54 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 327.56 | 300 | 98,268 | 18,648 | 18.9 K to 18.6 K (-1.58 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 325.36 | 200 | 65,072 | 18,948 | 19.1 K to 18.9 K (-1.04 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 324.81 | 100 | 32,481 | 19,148 | 19.2 K to 19.1 K (-0.52 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 323.30 | 3,142 | 1,015,809 | 19,248 | 22.4 K to 19.2 K (-14.03 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 323.30 | 710 | 229,543 | 22,390 | 23.1 K to 22.4 K (-3.07 %) |
Feb 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 30.63 | 7,500 | 229,725 | 23,100 | 15.6 K to 23.1 K (+48.08 %) |
Dec 17 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | A | 270.43 | 30,000 | 8,112,900 | 30,000 | |
Jun 18 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 3,900 | 93,600 | 11,064 | |
Jun 18 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 3,900 | 93,600 | 15,600 | 11.7 K to 15.6 K (+33.33 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 12,500 | 300,000 | 29,168 | |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 281.72 | 100 | 28,172 | 11,700 | 11.8 K to 11.7 K (-0.85 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 280.40 | 1,263 | 354,145 | 11,800 | 13.1 K to 11.8 K (-9.67 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 279.44 | 3,465 | 968,260 | 13,063 | 16.5 K to 13.1 K (-20.96 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 278.72 | 701 | 195,383 | 16,528 | 17.2 K to 16.5 K (-4.07 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 275.97 | 5,885 | 1,624,083 | 17,229 | 23.1 K to 17.2 K (-25.46 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 275.97 | 1,086 | 299,703 | 23,114 | 24.2 K to 23.1 K (-4.49 %) |
May 15 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 12,500 | 300,000 | 24,200 | 11.7 K to 24.2 K (+106.84 %) |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 1,600 | 38,400 | 41,668 | |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 6,734 | 161,616 | 43,268 | |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 256.46 | 1,600 | 410,336 | 11,700 | 13.3 K to 11.7 K (-12.03 %) |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 1,600 | 38,400 | 13,300 | 11.7 K to 13.3 K (+13.68 %) |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 257.29 | 6,734 | 1,732,591 | 11,700 | 18.4 K to 11.7 K (-36.53 %) |
May 08 2013 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 6,734 | 161,616 | 18,434 | 11.7 K to 18.4 K (+57.56 %) |
Dec 19 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 1,200 | 28,800 | 14,964 | |
Dec 19 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 1,200 | 28,800 | 11,700 | 10.5 K to 11.7 K (+11.43 %) |
Dec 17 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | A | 179.13 | 35,000 | 6,269,550 | 35,000 | |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 30.63 | 7,500 | 229,725 | 22,500 | |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 185.18 | 2,100 | 388,878 | 10,500 | 12.6 K to 10.5 K (-16.67 %) |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 184.85 | 1,268 | 234,390 | 12,600 | 13.9 K to 12.6 K (-9.14 %) |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 182.68 | 2,875 | 525,205 | 13,868 | 16.7 K to 13.9 K (-17.17 %) |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 182.68 | 1,257 | 229,629 | 16,743 | 18 K to 16.7 K (-6.98 %) |
Dec 12 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 30.63 | 7,500 | 229,725 | 18,000 | 10.5 K to 18 K (+71.43 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 8,334 | 200,016 | 50,002 | |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 184.00 | 100 | 18,400 | 10,500 | 10.6 K to 10.5 K (-0.94 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 183.77 | 200 | 36,754 | 10,600 | 10.8 K to 10.6 K (-1.85 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 182.39 | 200 | 36,478 | 10,800 | 11 K to 10.8 K (-1.82 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 181.59 | 400 | 72,636 | 11,000 | 11.4 K to 11 K (-3.51 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 180.08 | 3,004 | 540,960 | 11,400 | 14.4 K to 11.4 K (-20.86 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 182.20 | 3,333 | 607,273 | 14,404 | 17.7 K to 14.4 K (-18.79 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 182.20 | 1,097 | 199,873 | 17,737 | 18.8 K to 17.7 K (-5.82 %) |
Dec 03 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 8,334 | 200,016 | 18,834 | 10.5 K to 18.8 K (+79.37 %) |
May 25 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 500 | 12,000 | 16,164 | |
May 25 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 500 | 12,000 | 10,500 | 10 K to 10.5 K (+5.00 %) |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 12,500 | 300,000 | 58,336 | |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 135.29 | 2,300 | 311,167 | 10,000 | 12.3 K to 10 K (-18.70 %) |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 134.52 | 3,862 | 519,516 | 12,300 | 16.2 K to 12.3 K (-23.90 %) |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 138.31 | 4,170 | 576,753 | 16,162 | 20.3 K to 16.2 K (-20.51 %) |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 138.31 | 2,168 | 299,856 | 20,332 | 22.5 K to 20.3 K (-9.64 %) |
May 02 2012 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 12,500 | 300,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Dec 20 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | A | 52.03 | 35,000 | 1,821,050 | 35,000 | |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 8,334 | 200,016 | 70,836 | |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 4,166 | 99,984 | 16,664 | |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 70.39 | 1,577 | 111,005 | 10,000 | 11.6 K to 10 K (-13.62 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 69.57 | 900 | 62,613 | 11,577 | 12.5 K to 11.6 K (-7.21 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 68.80 | 700 | 48,160 | 12,477 | 13.2 K to 12.5 K (-5.31 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 67.39 | 200 | 13,478 | 13,177 | 13.4 K to 13.2 K (-1.50 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 65.76 | 1,916 | 125,996 | 13,377 | 15.3 K to 13.4 K (-12.53 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 65.76 | 3,041 | 199,976 | 15,293 | 18.3 K to 15.3 K (-16.59 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 8,334 | 200,016 | 18,334 | 10 K to 18.3 K (+83.34 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 64.00 | 4,166 | 266,624 | 10,000 | 14.2 K to 10 K (-29.41 %) |
Sep 07 2011 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 4,166 | 99,984 | 14,166 | 10 K to 14.2 K (+41.66 %) |
Dec 20 2010 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP, Strat and Inves ... | Option Exercise | A | 30.63 | 30,000 | 918,900 | 30,000 | |
Mar 24 2010 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP, Strat and Inves ... | Option Exercise | A | 24.00 | 79,170 | 1,900,080 | 79,170 | |
Mar 24 2010 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP, Strat and Inves ... | Option Exercise | A | 24.00 | 20,830 | 499,920 | 20,830 | |
Mar 24 2010 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP, Strat and Inves ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1